Conservative therapy of stage I endometrial adenocarcinoma and atypical endometrial hyperplasia for the preservation of fertility.
Chang
W-H
WH
Department of Obstetrics and Gynecology Tri-Service General Hospital, National Defense Medical Center, Neihu, Taipei, Taiwan.
Chen
C-H
CH
Yu
M-H
MH
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000328:Adult; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage / Q000627:therapeutic use*; D004714:Endometrial Hyperplasia / Q000188:drug therapy* / Q000601:surgery; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects; D007247:Infertility, Female / Q000517:prevention & control*; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D003280:Contraceptives, Oral, Synthetic; D008525:Medroxyprogesterone